Moreover, we found that the expression/activity of EZH2 was regulated both in vitro and in vivo models of HCC by a non-receptor tyrosine kinase called focal adhesion kinase (FAK) [10]. The gene discussed is PTK2; the disease is hepatocellular carcinoma.